Stockhouse.com uses cookies on this site. By continuing to use our service, you agree to our use of cookies. Cookies are used to offer you a better browsing experience and to analyze our traffic. We also use them to share usage information with our partners. See full details.
I Agree
×
Join today and have your say! It’s FREE!

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Please Try Again
{{ error }}
By providing my email, I consent to receiving investment related electronic messages from Stockhouse.

or

Privacy Policy | Disclaimer

Sign In

Please Try Again
{{ error }}
Password Hint : {{passwordHint}}
Forgot Password?

or

Privacy Policy | Disclaimer
Please Try Again {{ error }}

Send my password

Return to Login
SUCCESS
An email was sent with password retrieval instructions. Please go to the link in the email message to retrieve your password.

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.

Search Results

Refine Your Search

By Sector

Sort by: Date|Relevance

Stocks facing revaluation: Nel, Bayer, Power Nickel with potential

Relief for Bayer. In the U.S., the company has won a victory in the dispute over compensation for illnesses caused by the chemical PCB. Is it groundbreaking and the start of a revaluation of the stock? A revaluation already seems to be underway at Power Nickel. Follo...
Fabian Lorenz | May 9, 2024 |

ARway (CSE:ARWY) on the cusp of major deals

Our next company is an AI-powered platform providing people with an augmented reality experience through indoor and outdoor spaces. By utilizing the mini computers that are in most people’s pockets, i.e. phones, ARway leverages the power of these devices t...
Brieanna McCutcheon | May 4, 2023 |

Meet The Company That Is Giving Consumers Back Control of Their Own Data

(Click image to watch video) With offices in Toronto and New York, Killi Ltd. ( TSXV: MYID , OTCQB: MYIDD , Forum ) is a Canadian-based data company focused on data protection and privacy by allowing consumers to take back control of their data from those wh...
Jocelyn Aspa | May 11, 2021 |

The EV Battle is Heating Up: Enter “The Tesla Killer”

(IoniX Pro Home Smart Wall Product Rendering via Extreme Vehicle Battery Technologies Corp.) When it comes to the Electric Vehicle (EV) revolution, the future is imminent and those who have adopted this next level lifestyle agree that what they need is power … an...
Stockhouse Editorial | January 11, 2021 |

Shaping the Future of Medicine by Delivering Regenerative Medicines

(Click image to play video) Envision a chest pain that feels like the most severe form of heartburn you ever experienced before. This is one of the main symptoms of ischemia – a disease which millions of people around the globe live with every day. Treati...
Dave Jackson | December 8, 2020 |

A Unique Play in the Hungry US Hemp Market

(Image via Cascadia Extracts.) Utilizing high capacity CO 2 extraction equipment to tap into the extremely underserviced hemp market, Cascadia Extracts ( P. CASCADIA , Forum ) uses unique technology to take advantage of the significant benefits associated w...
Stockhouse Editorial | September 23, 2020 |

US Stock Market Enters Parabolic Price Move – Be Prepared, Part I

After the recent COVID-19 virus event and the global market concerns that will warrant caution for skilled traders and investors, the US stock markets have entered an upside parabolic trend that will likely end with a massive price collapse – extremely volatile and aggressiv...
Chris Vermeulen | June 23, 2020 |

DIAGNOS poised for parabolic move as first of new cardio AI Applications comes to market

DIAGNOS Inc. (TSX-V: ADK) (OTCQB: DGNOF) (Frankfurt: 4D4) is a Canadian-based healthcare software technology company that pioneered ' C omputer A ssisted R etinal A nalysis' (CARA), applying artificial intelligence to non-invasively test, identify, and classify patients a...
James O'Rourke | May 5, 2020 |

Gilead Drug May Cure COVID-19 But Won’t Save the Markets

Big news out today on CNBC about Gilead drug cured all 125 people from serious COVID-19 conditions within 5 days, This is amazing to hear, stocks are popping today up 3-5% which is to be expected for this type of news but the damage to the financial markets has already been ...
Chris Vermeulen | April 17, 2020 |

Fate Therapeutics Shares Rise 10% as First Person Treated with Its Anti-Cancer Therapy

Shares of Fate Therapeutics traded higher after the firm reported it has treated the first patient in a first-in-human trial of FT596 for patients with B-cell malignancies and chronic lymphocytic leukemia. Clinical-stage biopharmaceutical company Fate Thera...
Streetwise Reports | April 7, 2020 |
1 2 3 4 5